Growing community of inventors

Amsterdam Zuidoost, Netherlands

Martijn Kedde

Average Co-Inventor Count = 6.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Martijn KeddeHergen Spits (3 patents)Martijn KeddeMarijn Aletta Gillissen (3 patents)Martijn KeddeMette Deborah Hazenberg (3 patents)Martijn KeddeTim Beaumont (2 patents)Martijn KeddeAdrianus Quirinus Bakker (2 patents)Martijn KeddePaula Maria Wilhelmina Van Helden (1 patent)Martijn KeddeWouter Pos (1 patent)Martijn KeddeMartijn Kedde (3 patents)Hergen SpitsHergen Spits (25 patents)Marijn Aletta GillissenMarijn Aletta Gillissen (3 patents)Mette Deborah HazenbergMette Deborah Hazenberg (3 patents)Tim BeaumontTim Beaumont (29 patents)Adrianus Quirinus BakkerAdrianus Quirinus Bakker (16 patents)Paula Maria Wilhelmina Van HeldenPaula Maria Wilhelmina Van Helden (4 patents)Wouter PosWouter Pos (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Kling Biotherapeutics B.v. (2 from 4 patents)

2. Aimm Therapeutics B.v. (1 from 22 patents)


3 patents:

1. 11629200 - Means and methods for counteracting myeloproliferative or lymphoproliferative disorders

2. 11524989 - AML antigens and uses thereof

3. 10556963 - Means and methods for counteracting myeloproliferative or lymphoproliferative disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…